Philippe De Deurwaerdere
Team leader
University Teacher- Researcher/ Contact
+33 5 57 57 15 51
www.orcid.org/0000-0002-1226-3516
/ Address of work
INCIA - UMR 5287 - CNRS/Université de Bordeaux - Zone nord Bat 2 - 2e étage, 146, rue Léo-Saignat - 33076 Bordeaux cedex
Scientific articles
-
Serotonergic neurons are involved in the counter-regulatory response to hypoglycemia.
J Neuroendocrinology. 2023-10-19.
10.1111/jne.13344 -
Limiting Monoamines Degradation Increases L-DOPA Pro-Locomotor Action in Newborn Rats
IJMS. 2023-09-29. 24(19) : 14747.
10.3390/ijms241914747 -
Insulin modulates emotional behavior through a serotonin-dependent mechanism
Mol Psychiatry. 2022-10-07.
10.1038/S41380-022-01812-3 -
Deleting Snord115 genes in mice remodels monoaminergic systems activity in the brain toward cortico-subcortical imbalances
Human Molecular Genetics. 2022-08-11.
10.1093/HMG/DDAC139 -
Switch of serotonergic descending inhibition into facilitation by a spinal chloride imbalance in neuropathic pain
Sci. Adv.. 2022-07-29. 8(30)
10.1126/sciadv.abo0689 -
Cannabinoid 1/2 Receptor Activation Induces Strain-Dependent Behavioral and Neurochemical Changes in Genetic Absence Epilepsy Rats From Strasbourg and Non-epileptic Control Rats
Front. Cell. Neurosci.. 2022-05-23. 16
10.3389/FNCEL.2022.886033 -
Pathophysiology of the Serotonin System in the Nervous System and Beyond
IJMS. 2022-04-25. 23(9) : 4712.
10.3390/ijms23094712 -
Neurobiological and Pharmacological Perspectives of D3 Receptors in Parkinson’s Disease
Biomolecules. 2022-02-01. 12(2) : 243.
10.3390/biom12020243 -
Nicotine modulation of the lateral habenula/ventral tegmental area circuit dynamics: An electrophysiological study in rats
Neuropharmacology. 2022-01-01. 202 : 108859.
10.1016/J.NEUROPHARM.2021.108859 -
Simulated Microgravity Subtlety Changes Monoamine Function across the Rat Brain
IJMS. 2021-10-29. 22(21) : 11759.
10.3390/ijms222111759 -
L‐DOPA and 5‐HTP modulation of air‐stepping in newborn rats
J Physiol. 2021-09-05. 599(19) : 4455-4476.
10.1113/jp281983 -
Dopamine D3 Receptor: Contemporary Views of Its Function and Pharmacology for Neuropsychiatric Diseases
Biomolecules. 2021-05-11. 11(5) : 713.
10.3390/biom11050713 -
Lateral Habenula 5-HT2C Receptor Function Is Altered by Acute and Chronic Nicotine Exposures
Int. J. Mol. Sci. 2021-04-30.
10.3390/ijms22094775 -
Multiple facets of serotonergic modulation.
Progress in Brain Research. 2021-01-01. : 3-39.
10.1016/bs.pbr.2021.02.002 -
5-HT Interaction with Other Neurotransmitters: Experimental Evidence and Therapeutic Relevance Part B Preface
Progress in Brain Research. 2021-01-01. : xix.
10.1016/S0079-6123(21)00083-2 -
5-HT interaction with other neurotransmitters: An overview
Progress in Brain Research. 2021-01-01. : 1-5.
10.1016/BS.PBR.2021.01.001 -
Serotonergic control of the glutamatergic neurons of the subthalamic nucleus
Progress in Brain Research. 2021-01-01. : 423-462.
10.1016/BS.PBR.2020.11.003 -
Serotonin modulation of hippocampal functions: From anatomy to neurotherapeutics
Progress in Brain Research. 2021-01-01. : 83-158.
10.1016/BS.PBR.2021.01.031 -
Serotonin/dopamine interaction: Electrophysiological and neurochemical evidence
Progress in Brain Research. 2021-01-01. : 161-264.
10.1016/BS.PBR.2021.02.001 -
Serotonin research: Crossing scales and boundaries
Neuropharmacology. 2020-12-01. 181 : 108340.
10.1016/J.NEUROPHARM.2020.108340 -
Editorial: Contemporary Perspective on 5-HT2C Receptor Function and Its Pharmacological Targeting
Front. Pharmacol.. 2020-11-23. 11
10.3389/FPHAR.2020.606414 -
A Subset of Purposeless Oral Movements Triggered by Dopaminergic Agonists Is Modulated by 5-HT2C Receptors in Rats: Implication of the Subthalamic Nucleus
IJMS. 2020-11-12. 21(22) : 8509.
10.3390/ijms21228509 -
Mediterranean Neuroscience Methods 2019.
Journal of Neuroscience Methods. 2020-11-01. : 109010.
10.1016/j.jneumeth.2020.109010 -
Editorial: Non-Dopaminergic Systems in Parkinson’s Disease
Front. Pharmacol.. 2020-09-11. 11
10.3389/FPHAR.2020.593822 -
Chronic Administration of Fipronil Heterogeneously Alters the Neurochemistry of Monoaminergic Systems in the Rat Brain
IJMS. 2020-08-09. 21(16) : 5711.
10.3390/ijms21165711 -
Lorcaserin Alters Serotonin and Noradrenaline Tissue Content and Their Interaction With Dopamine in the Rat Brain
Front. Pharmacol.. 2020-06-30. 11
10.3389/fphar.2020.00962 -
Serotonin in Health and Disease
IJMS. 2020-05-15. 21(10) : 3500.
10.3390/ijms21103500 -
The Noradrenergic System in Parkinson’s Disease
Front. Pharmacol.. 2020-04-08. 11
10.3389/fphar.2020.00435 -
Lorcaserin bidirectionally regulates dopaminergic function site-dependently and disrupts dopamine brain area correlations in rats
Neuropharmacology. 2020-04-01. 166 : 107915.
10.1016/j.neuropharm.2019.107915 -
The pesticide fipronil injected into the substantia nigra of male rats decreases striatal dopamine content: A neurochemical, immunohistochemical and behavioral study
Behavioural Brain Research. 2020-04-01. 384 : 112562.
10.1016/j.bbr.2020.112562 -
Acute and chronic nicotine exposures differentially affect central serotonin 2A receptor function: Focus on the lateral habenula
IJMS. 2020-03-09. 21(5) : 1873.
10.3390/ijms21051873 -
Serotonin in Animal Cognition and Behavior
IJMS. 2020-02-28. 21(5) : 1649.
10.3390/ijms21051649 -
Old neurochemical markers, new functional directions?
J. Neurochem.. 2020-01-09.
10.1111/jnc.14929 -
L-DOPA in Parkinson’s Disease: Looking at the “False” Neurotransmitters and Their Meaning.
Int J Mol Sci.. 2019 Dec 31. 21(11)
10.3390/ijms21010294. -
Constitutive activity of 5-HT receptors: Factual analysis
Neuropharmacology. 2020-01-01. : 107967.
10.1016/j.neuropharm.2020.107967 -
Serotonergic control of excitability: from neuron to networks
Handbook of Behavioral Neuroscience. 2020-01-01. : 197-215.
10.1016/B978-0-444-64125-0.00010-4 -
L-DOPA in parkinson’s disease: Looking at the “false” neurotransmitters and their meaning
IJMS. 2019-12-31. 21(1) : 294.
10.3390/ijms21010294 -
Early neurochemical modifications of monoaminergic systems in the R6/1 mouse model of Huntington’s disease
Neurochemistry International. 2019-09-01. 128 : 186-195.
10.1016/j.neuint.2019.05.001 -
Reciprocal interaction between monoaminergic systems and the pedunculopontine nucleus: Implication in the mechanism of L-DOPA
Neurobiology of Disease. 2019-08-01. 128 : 9-18.
10.1016/j.nbd.2018.08.014 -
Effect of the 5-HT2C Receptor Agonist WAY-163909 on Serotonin and Dopamine Metabolism across the Rat Brain: A Quantitative and Qualitative Neurochemical Study
IJMS. 2019-06-14. 20(12) : 2925.
10.3390/ijms20122925 -
Neurochemical impact of the 5-HT
2C receptor agonist WAY-163909 on monoamine tissue content in the rat brain
Neurochemistry International. 2019-03-01. 124 : 245-255.
10.1016/j.neuint.2019.01.019 -
Exogenous LRRK2G2019S induces parkinsonian-like pathology in a nonhuman primate
JCI Insight. 2018-07-25. 3(14)
10.1172/jci.insight.98202 -
Alteration of nociceptive integration in the spinal cord of a rat model of Parkinson’s disease
Mov Disord.. 2018-05-18. 33(6) : 1010-1015.
10.1002/mds.27377 -
Lead-induced atypical Parkinsonism in rats: Behavioral, electrophysiological, and neurochemical evidence for a role of noradrenaline depletion
Front. Neurosci.. 2018-03-19. 12
10.3389/fnins.2018.00173 -
Inter-individual differences in the impulsive/compulsive dimension: deciphering related dopaminergic and serotonergic metabolisms at rest
Phil. Trans. R. Soc. B. 2018-02-26. 373(1744) : 20170154.
10.1098/rstb.2017.0154 -
Preferential modulation of the lateral habenula activity by serotonin-2A rather than -2C receptors: Electrophysiological and neuroanatomical evidence
CNS Neurosci Ther. 2018-02-25. 24(8) : 721-733.
10.1111/cns.12830 -
Preferential modulation of the lateral habenula activity by serotonin‐2A rather than ‐2C receptors: Electrophysiological and neuroanatomical evidence
CNS Neurosci Ther. 2018-02-25. 24(8) : 721-733.
10.1111/cns.12830 -
5-HT
2A receptors in the basal ganglia
5-HT2A Receptors in the Central Nervous System. 2018-01-01. : 273-310.
10.1007/978-3-319-70474-6_12 -
Pharmacological analysis in favour of a physiological role for the constitutive activity of 5-HT
2A receptors in learning
5-HT2A Receptors in the Central Nervous System. 2018-01-01. : 3-29.
10.1007/978-3-319-70474-6_1 -
Role of serotonin2A (5-HT
2A ) receptors in epilepsy
5-HT2A Receptors in the Central Nervous System. 2018-01-01. : 375-394.
10.1007/978-3-319-70474-6_16 -
Purposeless oral activity induced by meta-chlorophenylpiperazine (m-CPP): Undefined tic-like behaviors?
Journal of Neuroscience Methods. 2017-12-01. 292 : 30-36.
10.1016/j.jneumeth.2017.05.007 -
Does the Serotonin2C receptor segregate circuits of the basal ganglia responding to cingulate cortex stimulation?
CNS Neurosci Ther. 2017-11-15. 24(8) : 741-744.
10.1111/cns.12777 -
Impairment of serotonergic transmission by the antiparkinsonian drug L-DOPA: Mechanisms and clinical implications
Front. Cell. Neurosci.. 2017-09-12. 11
10.3389/fncel.2017.00274 -
Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications
Progress in Neurobiology. 2017-04-01. 151 : 175-236.
10.1016/j.pneurobio.2016.03.004 -
Expanding the repertoire of L-DOPA’s actions: A comprehensive review of its functional neurochemistry
Progress in Neurobiology. 2017-04-01. 151 : 57-100.
10.1016/j.pneurobio.2016.07.002 -
Neurobiology and neuropharmacology of monoaminergic systems
Progress in Neurobiology. 2017-04-01. 151 : 1-3.
10.1016/j.pneurobio.2017.02.001 -
Correlative analysis of dopaminergic and serotonergic metabolism across the brain to study monoaminergic function and interaction
Journal of Neuroscience Methods. 2017-03-01. 280 : 54-63.
10.1016/j.jneumeth.2017.01.020 -
Comparative Analysis of the Neurochemical Profile and MAO Inhibition Properties of N-(Furan-2-ylmethyl)-N-methylprop-2-yn-1-amine
ACS Chem. Neurosci.. 2016-12-30. 8(5) : 1026-1035.
10.1021/acschemneuro.6b00377 -
Cortico-subthalamic inputs from the motor, limbic, and associative areas in normal and dopamine-depleted rats are not fully segregated
Brain Struct Funct. 2016-12-24. 222(6) : 2473-2485.
10.1007/s00429-016-1351-5 -
Monoaminergic and histaminergic strategies and treatments in brain diseases
Front. Neurosci.. 2016-11-24. 10
10.3389/fnins.2016.00541 -
Monoaminergic mechanisms in epilepsy may offer innovative therapeutic opportunity for monoaminergic multi-target drugs
Front. Neurosci.. 2016-11-10. 10
10.3389/fnins.2016.00492 -
L-DOPA elicits non-vesicular releases of serotonin and dopamine in hemiparkinsonian rats in vivo
European Neuropsychopharmacology. 2016-08-01. 26(8) : 1297-1309.
10.1016/j.euroneuro.2016.05.004 -
Updating neuropathology and neuropharmacology of monoaminergic systems
British Journal of Pharmacology. 2016-06-14. 173(13) : 2065-2068.
10.1111/bph.13508 -
The acute and long-term L-DOPA effects are independent from changes in the activity of dorsal raphe serotonergic neurons in 6-OHDA lesioned rats
British Journal of Pharmacology. 2016-03-08. 173(13) : 2135-2146.
10.1111/bph.13447 -
New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders.
Pharmacology & Therapeutics. 2016-01-01. 157 : 125-162.
10.1016/j.pharmthera.2015.11.009 -
Cariprazine: New dopamine biased agonist for neuropsychiatry disorders
Drugs Today. 2016-01-01. 52(2) : 97.
10.1358/dot.2016.52.2.2461868 -
The impact of combined administration of paraquat and maneb on motor and non-motor functions in the rat
Neuroscience. 2015-12-01. 311 : 118-129.
10.1016/j.neuroscience.2015.10.021 -
Monoamine content during the reproductive cycle of Perna perna depends on site of origin on the Atlantic Coast of Morocco.
Sci Rep. 2015-09-09. 5(1)
10.1038/srep13715 -
Monoamine content during the reproductive cycle of Perna perna depends on site of origin on the Atlantic Coast of Morocco
Sci Rep. 2015-09-09. 5(1)
10.1038/srep13715 -
The 5-HT4 Agonist Prucalopride Stimulates L-DOPA-Induced Dopamine Release in Restricted Brain Regions of the Hemiparkinsonian Rat In Vivo.
CNS Neurosci Ther. 2015-07-24. 21(9) : 745-747.
10.1111/cns.12436 -
The 5-HT<inf>4</inf> Agonist Prucalopride Stimulates L-DOPA-Induced Dopamine Release in Restricted Brain Regions of the Hemiparkinsonian Rat In Vivo
CNS Neurosci Ther. 2015-07-24. 21(9) : 745-747.
10.1111/cns.12436 -
Serotonin, but not dopamine, controls the stress response and anxiety-like behavior in the crayfish Procambarus clarkii.
Journal of Experimental Biology. 2015-07-02. 218(17) : 2745-2752.
10.1242/jeb.120550 -
Blood withdrawal affects iron store dynamics in primates with consequences on monoaminergic system function
Neuroscience. 2015-04-01. 290 : 621-635.
10.1016/j.neuroscience.2015.01.057 -
NMDA receptor antagonism potentiates the L-DOPA-induced extracellular dopamine release in the subthalamic nucleus of hemi-parkinson rats.
Neuropharmacology. 2014-10-01. 85 : 198-205.
10.1016/j.neuropharm.2014.05.024 -
Role(s) of the 5-HT2C receptor in the development of maximal dentate activation in the hippocampus of anesthetized rats (vol 20, pg 651, 2014)
CNS Neurosci Ther. 2014-09-26. 20(10) : 950-950.
10.1111/CNS.12324 -
Role(s) of the 5-HT2C receptor in the development of maximal dentate activation in the hippocampus of anesthetized rats.
CNS Neurosci Ther. 2014-06-17. 20(7) : 651-661.
10.1111/cns.12285 -
Role(s) of the 5-HT2C receptor in the development of maximal dentate activation in the hippocampus of anesthetized rats
CNS Neurosci Ther. 2014-06-17. 20(7) : 651-661.
10.1111/cns.12285 -
Anxiety-like behavior in crayfish is controlled by serotonin
Science. 2014-06-12. 344(6189) : 1293-1297.
10.1126/science.1248811 -
Manganese-induced atypical parkinsonism is associated with altered Basal Ganglia activity and changes in tissue levels of monoamines in the rat.
PLoS ONE. 2014-06-04. 9(6) : e98952.
10.1371/journal.pone.0098952 -
N-(furan-2-ylmethyl)-N-methylprop-2-yn-1-amine (F2MPA): A potential cognitive enhancer with MAO inhibitor properties.
CNS Neurosci Ther. 2014-05-21. 20(7) : 633-640.
10.1111/cns.12284 -
N-(furan-2-ylmethyl)-N-methylprop-2-yn-1-amine (F2MPA): A potential cognitive enhancer with MAO inhibitor properties
CNS Neurosci Ther. 2014-05-21. 20(7) : 633-640.
10.1111/cns.12284 -
Noradrenergic terminals regulate L-DOPA-derived dopamine extracellular levels in a region-dependent manner in Parkinsonian rats.
CNS Neurosci Ther. 2014-04-28. 20(7) : 671-678.
10.1111/cns.12275 -
Noradrenergic terminals regulate l-DOPA-derived dopamine extracellular levels in a region-dependent manner in Parkinsonian rats
CNS Neurosci Ther. 2014-04-28. 20(7) : 671-678.
10.1111/cns.12275 -
Predicting dopaminergic effects of L-DOPA in the treatment for Parkinson’s disease.
CNS Neurosci Ther. 2014-03-15. 20(7) : 699-701.
10.1111/cns.12252 -
Predicting dopaminergic effects of L-DOPA in the treatment for Parkinson’s disease
CNS Neurosci Ther. 2014-03-15. 20(7) : 699-701.
10.1111/cns.12252 -
L-DOPA and the Brain Pattern of Dopamine Extracellular Levels: A New Deal Imposed by Serotonergic and Noradrenergic Fibres
Catecholamine Research in the 21st Century. 2014-01-01. : 251.
10.1016/B978-0-12-800044-1.00221-X -
Role of central serotonin receptors in nicotine addiction
Nicotinic Receptors. 2014-01-01. : 279-305.
10.1007/978-1-4939-1167-7_14 -
Monoamines tissue content analysis reveals restricted and site-specific correlations in brain regions involved in cognition
Neuroscience. 2013-12-01. 255 : 233-245.
10.1016/j.neuroscience.2013.09.059 -
Serotonin2c receptor constitutive activity: in vivo direct and indirect evidence and functional significance.
CNSAMC. 2013-10-01. 13(2) : 98-107.
10.2174/1871524911313020002 -
A tobacco extract containing alkaloids induces distinct effects compared to pure nicotine on dopamine release in the rat.
Neuroscience Letters. 2013-06-01. 544 : 85-88.
10.1016/j.neulet.2013.03.047 -
Role of 5-HT2C receptors in the enhancement of c-Fos expression induced by a 5-HT2B/2C inverse agonist and 5-HT2 agonists in the rat basal ganglia
Exp Brain Res. 2013-05-17. 230(4) : 525-535.
10.1007/s00221-013-3562-9 -
Multiple controls exerted by 5-HT
2C receptors upon basal ganglia function: From physiology to pathophysiology
Exp Brain Res. 2013-04-25. 230(4) : 477-511.
10.1007/s00221-013-3508-2 -
Serotonin
2C ligands exhibiting full negative and positive intrinsic activity elicit purposeless oral movements in rats: Distinct effects of agonists and inverse agonists in a rat model of Parkinson’s disease
International Journal of Neuropsychopharmacology. 2013-04-01. 16(3) : 593-606.
10.1017/S1461145712000417 -
Serotonin2C ligands exhibiting full negative and positive intrinsic activity elicit purposeless oral movements in rats: distinct effects of agonists and inverse agonists in a rat model of Parkinson’s disease.
International Journal of Neuropsychopharmacology. 2013-04-01. 16(3) : 593-606.
10.1017/S1461145712000417 -
Intrapallidal administration of 6-hydroxydopamine mimics in large part the electrophysiological and behavioral consequences of major dopamine depletion in the rat
Neuroscience. 2013-04-01. 236 : 289-297.
10.1016/j.neuroscience.2013.01.043 -
The enhanced oral response to the 5-HT
2 agonist Ro 60-0175 in parkinsonian rats involves the entopeduncular nucleus: Electrophysiological correlates
Exp Brain Res. 2013-03-28. 230(4) : 513-524.
10.1007/s00221-013-3478-4 -
Serotonin2C Receptors and the Motor Control of Oral Activity.
CN. 2013-03-01. 11(2) : 160-170.
10.2174/1570159X11311020003 -
Catecholamine/Serotonin interactions: systems thinking for brain function and disease.
A New Era of Catecholamines in the Laboratory and Clinic. 2013-01-01. : 167-197.
10.1016/B978-0-12-411512-5.00009-9 -
What can we expect from the serotonergic side of l-DOPA? | Que pouvons-nous attendre de la composante sérotoninergique de la l-DOPA ?
Revue Neurologique. 2012-12-01. 168(12) : 927-938.
10.1016/j.neurol.2012.01.585 -
Lead intoxication induces noradrenaline depletion, motor nonmotor disabilities, and changes in the firing pattern of subthalamic nucleus neurons
Neuroscience. 2012-05-01. 210 : 375-383.
10.1016/j.neuroscience.2012.02.026 -
Emerging dysfunctions consequent to combined monoaminergic depletions in parkinsonism
Neurobiology of Disease. 2012-02-01. 45(2) : 763-773.
10.1016/j.nbd.2011.10.023 -
Contribution of serotonergic transmission to the motor and cognitive effects of high-frequency stimulation of the subthalamic nucleus or levodopa in Parkinson’s disease
Mol Neurobiol. 2012-01-06. 45(1) : 173-185.
10.1007/s12035-011-8230-0 -
L-DOPA and serotonergic neurons: functional implication and therapeutic perspectives in Parkinson’s disease.
CNSAMC. 2011-12-01. 11(4) : 305-320.
10.2174/1871524911106040305 -
Chronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson’s disease
Neurobiology of Disease. 2011-02-01. 41(2) : 585-590.
10.1016/j.nbd.2010.11.007 -
Noradrenaline and Parkinson’s disease
Front. Syst. Neurosci.. 2011-01-01. 5
10.3389/fnsys.2011.00031 -
Presynaptic control of serotonin on striatal dopamine function
Psychopharmacology. 2010-10-16. 213(2-3) : 213-242.
10.1007/s00213-010-2029-y -
Serotonergic neurons mediate ectopic release of dopamine induced by l-DOPA in a rat model of Parkinson’s disease
Neurobiology of Disease. 2010-04-01. 38(1) : 136-143.
10.1016/j.nbd.2010.01.012 -
High-frequency stimulation of the subthalamic nucleus and L-3,4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and hippocampus in a rat model of Parkinson’s disease
Journal of Neuroscience. 2010-02-10. 30(6) : 2356-2364.
10.1523/JNEUROSCI.5031-09.2010 -
Clozapine and haloperidol differentially alter the constitutive activity of central serotonin2C receptors in vivo
Biological Psychiatry. 2006-03-01. 59(6) : 568-575.
10.1016/j.biopsych.2005.07.035 -
Clozapine and haloperidol differentially alter the constitutive activity of central serotonin2C receptors in vivo
Biological Psychiatry. 2006-03-01. 59(6) : 568-575.
10.1016/j.biopsych.2005.07.035 -
Regionally and functionally distinct serotonin3 receptors control in vivo dopamine outflow in the rat nucleus accumbens
J Neurochem. 2005-07-01. 94(1) : 140-149.
10.1111/j.1471-4159.2005.03174.x -
Constitutive Activity of the Serotonin2C Receptor Inhibits In Vivo Dopamine Release in the Rat Striatum and Nucleus Accumbens
Journal of Neuroscience. 2004-03-31. 24(13) : 3235-3241.
10.1523/JNEUROSCI.0112-04.2004 -
Intrastriatal administration of sigma ligands inhibits basal dopamine release in vivo
Neuropharmacology. 2003-12-01. 45(7) : 945-953.
10.1016/S0028-3908(03)00253-3 -
In Vivo Evidence that 5-HT2C Receptor Antagonist but not Agonist Modulates Cocaine-Induced Dopamine Outflow in the Rat Nucleus Accumbens and Striatum
Neuropsychopharmacol. 2003-10-15. 29(2) : 319-326.
10.1038/sj.npp.1300329 -
In Vivo Evidence that 5-HT2C Receptor Antagonist but not Agonist Modulates Cocaine-Induced Dopamine Outflow in the Rat Nucleus Accumbens and Striatum
Neuropsychopharmacol. 2003-10-15. 29(2) : 319-326.
10.1038/sj.npp.1300329 -
Selective serotonin reuptake inhibitors enhance cocaine-induced locomotor activity and dopamine release in the nucleus accumbens
Neuropharmacology. 2003-03-01. 44(3) : 342-353.
10.1016/S0028-3908(02)00381-7 -
Conditional involvement of striatal serotonin3 receptors in the control of in vivo dopamine outflow in the rat striatum
European Journal of Neuroscience. 2003-02-01. 17(4) : 771-781.
10.1046/j.1460-9568.2003.02512.x -
Central serotonin
4 receptors selectively regulate the impulse-dependent exocytosis of dopamine in the rat striatum: In vivo studies with morphine, amphetamine and cocaine
Neuropharmacology. 2002-12-01. 43(7) : 1099-1109.
10.1016/S0028-3908(02)00212-5 -
Central serotonin4 receptors selectively regulate the impulse-dependent exocytosis of dopamine in the rat striatum: In vivo studies with morphine, amphetamine and cocaine
Neuropharmacology. 2002-12-01. 43(7) : 1099-1109.
10.1016/S0028-3908(02)00212-5 -
Central 5-HT
4 receptors and dopamine-dependent motor behaviors: Searching for a functional role
Pharmacology Biochemistry and Behavior. 2002-04-01. 71(4) : 627-633.
10.1016/S0091-3057(01)00703-1 -
Central 5-HT4 receptors and dopamine-dependent motor behaviors: Searching for a functional role
Pharmacology Biochemistry and Behavior. 2002-04-01. 71(4) : 627-633.
10.1016/S0091-3057(01)00703-1 -
5-HT
2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum
Neuropsychopharmacology. 2002-03-01. 26(3) : 311-324.
10.1016/S0893-133X(01)00333-5 -
5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum
Neuropsychopharmacology. 2002-03-01. 26(3) : 311-324.
10.1016/S0893-133X(01)00333-5 -
D-amphetamine-induced behavioral sensitization: Effect of lesioning dopaminergic terminals in the medial prefrontal cortex, the amygdala and the entorhinal cortex
Neuroscience. 2002-02-01. 109(3) : 499-516.
10.1016/S0306-4522(01)00508-5 -
Role of serotonin(2A) and serotonin(2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation
Journal of Neurochemistry. 2001-12-25. 73(3) : 1033-1042.
10.1046/j.1471-4159.1999.0731033.x -
The nigrostriatal dopamine system: A neglected target for 5-HT2C receptors (1)
Trends in Pharmacological Sciences. 2001-10-01. 22(10) : 502-503.
10.1016/S0165-6147(00)01811-3 -
Neurochemical and electrophysiological evidence that 5-HT4 receptors exert a state-dependent facilitatory control in vivo on nigrostriatal, but not mesoaccumbal, dopaminergic function
European Journal of Neuroscience. 2001-03-01. 13(5) : 889-898.
10.1046/j.0953-816X.2000.01453.x -
Endogenous serotonin enhances the release of dopamine in the striatum only when nigro-striatal dopaminergic transmission is activated
Neuropharmacology. 2000-10-01. 39(11) : 1984-1995.
10.1016/S0028-3908(00)00020-4 -
The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: Opposite role of 5-HT(2A) and 5-HT(2C) receptor subtypes and significance of the haloperidol dose used
Neuropharmacology. 2000-05-01. 39(6) : 1053-1063.
10.1016/S0028-3908(99)00193-8 -
Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: A combined in vivo electrophysiological and microdialysis study
Neuroscience. 1999-06-01. 91(2) : 587-597.
10.1016/S0306-4522(98)00655-1 -
8-OH-DPAT, a 5-HT(1a) agonist and ritanserin, a 5-HT(2A/C) antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release
Psychopharmacology. 1997-05-15. 131(1) : 57-63.
10.1007/s002130050265 -
Evidence for 5-HT
4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane-anesthetized rat
Neuropharmacology. 1995-03-01. 34(3) : 269-279.
10.1016/0028-3908(94)00145-I